http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1905466-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_485be38d1f4ab2ea21833e84dc1d4e4d
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-1723
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2210-0693
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-14292
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16Z99-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-172
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16Z99-00
filingDate 2006-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81ae5c7d25becac717b278e574fe959d
publicationDate 2008-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1905466-A1
titleOfInvention Identification of an infusion region in the heterogeneous tissue
abstract The present application relates to a method for determining at least one infusion and / or injection area (A5) for injecting a medical active substance into an anisotropic body structure (10), in particular biological tissue, in order to determine an effect of the medical active substance in a desired target area (A1) heterogeneous body structure (10), with the following steps:nproviding at least one property of the heterogeneous body structure (10) that affects the spatial distribution of the medical agent in the heterogeneous body structure (10);nthe at least one infusion and / or injection region (A5), from which a transport of the medicinal active substance through the anisotropic body structure to the at least one effective range is to take place, becomes at least dependent on the at least one property of the heterogeneous body structure and a position of the desired determined at least one effective range (A1).
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9152766-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012116747-A1
priorityDate 2006-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1396233-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006085288-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1316324-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0185230-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129978672
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400643
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3440

Total number of triples: 27.